{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-23-001070","form_type":"8-K","ticker":"STEX","cik":"0001530766","company_name":"Streamex Corp.","filed_at":"2023-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.392743+00:00","generated_at":"2026-06-09T23:17:00.817109+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BioSig raises $597K in registered PIPE, issuing ~1.13M shares and warrants","bullets":["Issued 1,129,996 shares at $0.52876/share and warrants for 564,998 shares at $0.46626.","Gross proceeds of $597,496.72; warrants exercisable 6 months out, expire in 5.5 years.","Laidlaw receives warrant for 84,750 shares as compensation for introducing the PIPE.","Securities sold under Section 4(a)(2) & Regulation D; reliance on exemption from registration."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-23-001070","json":"https://secwatch.observer/filing/0001185185-23-001070.json","markdown":"https://secwatch.observer/filing/0001185185-23-001070.md","text":"https://secwatch.observer/filing/0001185185-23-001070.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523001070/0001185185-23-001070-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523001070/biosig20231013_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T23:17:00.817109+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9d2134a37ac403df82095dfa13f513daeb41bd84","claim":"Streamex Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $597,496.72 (effective 2023-10-12).","evidence_excerpt":"On October 12, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 1,129,996 shares (the “Shares”) of the Company’s common stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523001070/0001185185-23-001070-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"$597,496.72"},{"label":"Effective","value":"2023-10-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}